Isolation and characterization of novel inhibitors of sphingolipid synthesis: australifungin, viridiofungins, rustmicin, and khafrefungin.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Methods in Enzymology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0076-6879(00)11094-8PMID 10563338
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rustmicin, a Potent Antifungal Agent, Inhibits Sphingolipid Synthesis at Inositol Phosphoceramide Synthase*

  1998cited by this paper
• Fermentation studies of rustmicin production by a Micromonospora sp.

  1998cited by this paper
• Synthesis of viridiofungin A trimethyl ester and determination of the absolute structure of viridiofungin A

  1998cited by this paper
• Natural products isolation

  1998cited by this paper
• Inhibition of fungal sphingolipid biosynthesis by rustmicin, galbonolide B and their new 21-hydroxy analogs.

  1998cited by this paper
• Sphingolipid Synthesis as a Target for Antifungal Drugs

  1997cited by this paper
• Determination of the Absolute Stereochemistry of (-)-Galbonolide A.

  1997cited by this paper
• Antimicrobial activity of viridiofungins.

  1997cited by this paper
• Khafrefungin, a Novel Inhibitor of Sphingolipid Synthesis*

  1997cited by this paper
• Viridiofungins, novel inhibitors of sphingolipid synthesis.

  1997cited by this paper
• Fumonisins: fungal toxins that shed light on sphingolipid function.

  1996cited by this paper
• Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.

  1995cited by this paper
• The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity.

  1995cited by this paper
• Structure Elucidation of Australifungin, a Potent Inhibitor of Sphinganine N-Acyltransferase in Sphingolipid Biosynthesis from Sporormiella australis

  1995cited by this paper
• Mechanism of Fumonisin Toxicity and Carcinogenesis.

  1994cited by this paper
• Inhibition of serine palmitoyl-transferase activity by lipoxamycin.

  1994cited by this paper
• Mechanism of Fumonisin Toxicity and Carcinogenesis.

  1994cited by this paper
• Isolation and structure elucidation of viridiofungins A, B and C

  1993cited by this paper
• Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic.

  1993cited by this paper
• Sphingofungins E and F: novel serinepalmitoyl transferase inhibitors from Paecilomyces variotii.

  1992cited by this paper
• Sphingofungins A, B, C, and D; a new family of antifungal agents. I. Fermentation, isolation, and biological activity.

  1992cited by this paper
• Characterization of a novel, potent, and specific inhibitor of serine palmitoyltransferase.

  1992cited by this paper
• Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.

  1991cited by this paper
• Fumonisins--novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme

  1988cited by this paper
• The Galbonolides

  1988cited by this paper
• Rustmicin, a new macrolide antibiotic active against wheat stem rust fungus.

  1987cited by this paper
• High-speed countercurrent chromatography

  1987cited by this paper
• Galbonolides A and B - two new non-glycosidic antifungal macrolides from streptomyces galbus

  1985cited by this paper
• Neorustmicin A, a new macrolide antibiotic active against wheat stem rust fungus.

  1985cited by this paper

• Beyond antibiotics: the expanding horizon of microbial natural products

  2026cites this paper
• Sphinganine C4-Hydroxylase MoSur2 Regulates Lipid Homeostasis and Cell Development in Magnaporthe oryzae.

  2025cites this paper
• Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology

  2024cites this paper
• Insights into the role of sphingolipids in antifungal drug resistance

  2024cites this paper
• Update on fungal lipid biosynthesis inhibitors as antifungal agents.

  2023cites this paper
• A world tour in the name of natural products.

  2022cites this paper
• Fungal resources: Current utilization, future prospects, and challenges

  2021cites this paper
• Total Synthesis of Viridiofungins A and B.

  2021cites this paper
• Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway

  2020cites this paper
• Long and Very-Long-Chain Ceramides Correlate with A More Aggressive Behavior in Skull Base Chordoma Patients

  2019cites this paper
• Anti-Cryptococcus Phenalenones and Cyclic Tetrapeptides from Auxarthron pseudauxarthron.

  2017cites this paper
• Lipid Metabolism in Model Fungi: The Achilles Heel of Fungal Pathogens

  2016cites this paper
• Sphingolipids as targets for treatment of fungal infections.

  2016cites this paper
• Targeting of the Hydrophobic Metabolome by Pathogens

  2015cites this paper
• Heterologous expression of galbonolide biosynthetic genes in Streptomyces coelicolor

  2015cites this paper
• TORC2-dependent protein kinase Ypk1 phosphorylates ceramide synthase to stimulate synthesis of complex sphingolipids

  2014cites this paper
• Isolation, structure, and biological activity of Phaeofungin, a cyclic lipodepsipeptide from a Phaeosphaeria sp. Using the Genome-Wide Candida albicans Fitness Test.

  2013cites this paper
• Ceramide synthases at the centre of sphingolipid metabolism and biology.

  2012cites this paper
• Members 5 and 6 of the Candida albicans BMT family encode enzymes acting specifically on β-mannosylation of the phospholipomannan cell-wall glycosphingolipid.

  2012cites this paper
• Molecular and functional characterization of the ceramide synthase from Trypanosoma cruzi.

  2012influential citation
• Highly stereoselective C-C bond formation by rhodium-catalyzed tandem ylide formation/[2,3]-sigmatropic rearrangement between donor/acceptor carbenoids and chiral allylic alcohols.

  2012cites this paper
• FEI Life Sciences The premier provider of 3 D ultrastructural imaging solutions for the life sciences

  2010cites this paper
• Total synthesis of sphingofungin F based on chiral tricyclic iminolactone.

  2010cites this paper
• Isolation, structure and biological activity of phomafungin, a cyclic lipodepsipeptide from a widespread tropical Phoma sp.

  2009cites this paper
• Inhibition of Inositol Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A

  2009cites this paper
• Functional interactions between sphingolipids and sterols in biological membranes regulating cell physiology.

  2009cites this paper
• Composition pharmaceutique pour le traitement ou la prévention d'une infection par le virus de l'hépatite b (vhb)

  2009cites this paper
• Water-compatible organocatalysts for direct asymmetric syn-aldol reactions of dihydroxyacetone and aldehydes.

  2008cites this paper
• Thematic Review Series: Sphingolipids. Biodiversity of sphingoid bases (“sphingosines”) and related amino alcohols

  2008cites this paper
• Total synthesis of khafrefungin using highly stereoselective vinylogous Mukaiyama aldol reaction.

  2007cites this paper
• Ceramide and other sphingolipids in cellular responses

  2007cites this paper
• Sphingolipid biosynthesis in pathogenic fungi: identification and characterization of the 3-ketosphinganine reductase activity of Candida albicans and Aspergillus fumigatus.

  2006cites this paper
• Glycosphingolipid structural analysis and glycosphingolipidomics.

  2005cites this paper
• Candida albicans serotype B strains synthesize a serotype‐specific phospholipomannan overexpressing a β‐1,2‐linked mannotriose

  2005cites this paper
• Ester dienolate [2,3]-Wittig rearrangement in natural product synthesis: diastereoselective total synthesis of the triester of viridiofungin A, A2, and A4.

  2005cites this paper
• Biological Activities of Fungal Metabolites

  2005cites this paper
• Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis

  2005cites this paper
• Nuevos fármacos basados en productos naturales de origen microbiano

  2004cites this paper
• An introduction to plant sphingolipids and a review of recent advances in understanding their metabolism and function.

  2004cites this paper
• Metabolism and physiological functions of sphingolipids

  2003cites this paper
• Yeast sphingolipid bypass mutants as indicators of antifungal agents selectively targeting sphingolipid synthesis.

  2003cites this paper
• Sphingolipids are essential for differentiation but not growth in Leishmania

  2003cites this paper
• Microbial natural products as a source of antifungals.

  2003influential citation
• syn-Selective additions to Garner aldehyde: synthesis of a potent glucosylceramide synthase inhibitor

  2002cites this paper
• Antifungal Drug Discovery: Old Drugs, New Tools

  2002cites this paper
• De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway*

  2002cites this paper
• Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption.

  2001cites this paper
• gem-Diacetates as carbonyl surrogates for asymmetric synthesis. Total syntheses of sphingofungins E and F.

  2001cites this paper
• Antifungal antibiotics

  2001cites this paper
• Compilation of methods published in previous volumes of Methods in Enzymology.

  2000cites this paper
• New potential targets for antifungal development

  2000cites this paper